RBC PRE-MKT INDICATIONS
ACCOR +1% Q3 sales beat but lower top end of '16 forecasts as expected
AIX/LIGHT -2% CREE (-9.7%) earnings miss/warning after hours
AKSO NOBEL +1% Q3 revenues miss, French paint challenging, but EBIT ahead
ASML 0% Q3 bookings beat, outlook confirmed but EUV units cut again
BHP -1% Production report inline but copper miss, guidance reit.
CARREFOUR +2% Q3 sales & LFL beat, France ahead, Brazil better & supers
ELISA 0% Q3 rev/EBITDA a tad ahead of cons, Estonia better, Finland worse
EUROTUNNEL -1% Q3 revs miss at headline, shuttle traffic know, Eurostar worse
HANDELSBNK +2% Net profit 2% ahead of cons, NII also ahead.
METRO +1% Q4 sales inline, confirms FY guidance - nothing done.
RECKITTS -2% Q3 lfl +2% v +2.5% expected, Revs inline FY target at low end
RENTOKIL +2% Q3 statement, trading inline, reit guidance. Hygiene ahead.
THALES +2% Q3 sales growth ahead and reiterating guidance
TRAVIS P. -5% Mixed earnings, Sales small beat but lower EBITDA guidance
VW +3% FT reports judge in US "strongly inclined" to give final approval
WOLSELEY -1% Lowest ABI in 4 yrs from the US, 48.4 v 49.7 last month
ZALANDO +1% Pre-release Q3. EBIT ahead, Sep. Weak, rev guidance at upper end
.Investec
* ACCOR-Q3 lfl +1.8%(est +0.7%),cuts top end guidance but very weak into.....+2%
* AKZO NOBEL-Q3 clean ebit 2% beat. Analyst comment follows..................+1%
* ASML-Q3 sales 5% ahead but net 3% miss, Q4 guidance unch...................+3%
* CARRERFOUR-Q3 overall sales in line, French supermarkets beat..............+1%
* CASINO-Rallye launches €200m bond, exchangeable into CO FP shares........-0.5%
* ELISA-Q3 sales and ebitda small ahead, keeps FY f/casts....................+1%
* ERICSSON-several candidates have turned down CEO role (DI)...............-0.5%
* FCA-recalls 75k vehicles in US over alternator issue.......................U/C
* INTRUM JUSTITIA-Q3 ebit 10% ahead on revs that were 4% ahead...............+2%
* METRO-Q4 sales in line, confirms f/cast, spin-off preparations on track....U/C
* ROCHE-Tecentriq approved for metastatic lung cancer........................+1%
* SHB- Q3 numbers all look in line/small beat,CET1 ratio 24% (cons 23.6%)...+1%
* THALES-Q3 sales 5% beat, raises FY order intake ests, keeps ebit ests......+2%
* VW-US judge ‘strongly inclined’ to approve $14.7bn settlement............+0.5%
* ZALANDO-Q3 ebit €8m vs expected €12m loss, raises FY op margin guidance....+3%
Other
* EU Co’s reporting later/after close: TEMENOS, MICHELIN
UK
* BILLITON-Q1 Prod.Iron Ore & Petrol ahead. Copper & Coal miss..............-1%
* FOXTONS-Update.Tight cost controls improves margins. FY broadly i/l.....+1-2%
* HARWORTH GRP-Completes plot sale to TAYLOR WIMPEY.......................+2-3%
* HOTEL CHOCOLAT-FY.#'s a small beat.Strategy remains on track.(-5% yday).+2-3%
* INTERSERVE-Hosting CMD in London today...................................unch
* LAIRD GRP-Q3.WARNING..U/L PTP c£50m(Bloomberg £73.6m)....................-20%
* RECKITTS-Q3.LFL Rev +2%(INVe +3.2%)Targets FY lfl 4%(July said 4-5%)......-2%
* RENTOKILL-Q3.Good organic growth, guidance for FY unchanged...............+2%
* SOFTCAT-FY#'s in line, Special Div 14.2p. Well placed.....................+2%
* TAPTICA-Codoon appoints TAP as exclusive mobile advertising partner......unch
* TRAVIS PERKINS-Q3.Sees FY EBITDA slightly below consensus...............-3-5%
* U&I-H1.£11.5m devel & trading gains in 1H (£8m guid)EPRA NAV lower @ 272p.+1%